Chausmer A L, Ettenberg A
Department of Psychology, University of California, Santa Barbara 93106, USA.
Pharmacol Biochem Behav. 1997 Aug;57(4):681-5. doi: 10.1016/s0091-3057(96)00388-7.
Although the reinforcing properties of food are reduced in the presence of dopamine antagonist drugs, controversy exists about the relative roles of D1 vs D2 receptor subtypes in the actions of these drugs. The current experiment compared the effects of raclopride (a selective D2 receptor antagonist) and SCH 39166 (a selective D1 receptor antagonist) in the response-reinstating effects of food reinforcement. Hungry rats were trained to run a straight-alley for food reinforcement during single daily trials. The operant was then extinguished during consecutive daily non-reinforced trials. Subjects were then injected with one of four doses of raclopride (0.0, 1.0, 0.5, and 0.25 mg/kg, i.p.) or SCH 39166 (0.0, 1.0, 0.5, and 0.1 mg/kg i.p.) 30 min prior to a single reinforced treatment trial. Twenty-four h later, a test trial was conducted in an unbaited runway. The single reinforced trial in the midst of extinction was observed to reinstate operant runway performance. Raclopride, but not SCH 39166, dose-dependently attenuated this reinstatement. Motor control groups ruled out the possibility that these results were due to differential residual motor effects of the drugs. Results suggest that D2, but not D1, dopamine receptors, are involved in the response-reinstating properties of food reinforcement.
尽管在多巴胺拮抗剂药物存在的情况下食物的强化特性会降低,但关于D1与D2受体亚型在这些药物作用中的相对作用仍存在争议。当前实验比较了雷氯必利(一种选择性D2受体拮抗剂)和SCH 39166(一种选择性D1受体拮抗剂)对食物强化恢复反应的影响。饥饿的大鼠在每日单次试验中被训练在直道上奔跑以获取食物强化。然后在连续的每日无强化试验中使该操作性行为消退。随后在单次强化治疗试验前30分钟,给受试者注射四种剂量之一的雷氯必利(0.0、1.0、0.5和0.25毫克/千克,腹腔注射)或SCH 39166(0.0、1.0、0.5和0.1毫克/千克,腹腔注射)。24小时后,在未放置诱饵的跑道上进行测试试验。观察到在消退过程中的单次强化试验恢复了操作性跑道表现。雷氯必利而非SCH 39166剂量依赖性地减弱了这种恢复。运动控制组排除了这些结果是由于药物的不同残留运动效应所致的可能性。结果表明,D2而非D1多巴胺受体参与了食物强化的反应恢复特性。